Pierre Tariot

Pierre Tariot

UNVERIFIED PROFILE

Are you Pierre Tariot?   Register this Author

Register author
Pierre Tariot

Pierre Tariot

Publications by authors named "Pierre Tariot"

Are you Pierre Tariot?   Register this Author

100Publications

2355Reads

9Profile Views

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.

N Engl J Med 2019 Apr;380(15):1408-1420

From Merck, Kenilworth, NJ (M.F.E., J.K., T.V., Y. Mukai, Y.Z., W.L., C.F., E.M., L.H.M., Y. Mo, C.S., D.M.); the University of Southern California, San Diego (P.S.A.); Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas (J.L.C.); Banner Alzheimer's Institute, Phoenix, AZ (P.N.T.); Gerontopole, INSERM Unité 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse, France (B.V.); Yale University School of Medicine, New Haven, CT (C.H.D.); and the Research Center and Memory Clínic, Fundació Alzheimer Centre Educacional, Institut Català de Neurociènces Aplicades-Universitat Internacional de Catalunya, Barcelona, and the Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid - both in Spain (M.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812840DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776078PMC
April 2019

Present Algorithms and Future Treatments for Alzheimer's Disease.

J Alzheimers Dis 2019 ;67(4):1157-1171

Banner Alzheimer's Institute, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-180903DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484274PMC
January 2019

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.

N Engl J Med 2018 05;378(18):1691-1703

From Merck Research Laboratories, Merck, Kenilworth, NJ (M.F.E., J.K., C.S., Y. Mukai, T.V., C.F., E.M., L.H.M., Y. Mo, D.M.); Banner Alzheimer's Institute, Phoenix, AZ (P.N.T.); University of Southern California, San Diego (P.S.A.); Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas (J.L.C.); Gerontopole, INSERM Unité 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, Toulouse, France (B.V.); and Leuven Institute of Neuroscience and Disease, Alzheimer Research Center, and the Laboratory for Cognitive Neurology, Department of Neurosciences, Katholieke Universiteit Leuven, and Neurology, University Hospitals - both in Leuven, Belgium (R.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776074PMC
May 2018

Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.

Neurology 2017 Oct 6;89(14):1464-1470. Epub 2017 Sep 6.

From Massachusetts General Hospital (D.J.N., R.A., B.P., R.A.S., Y.T.Q.); Harvard Medical School (D.J.N., R.A., R.A.S., Y.T.Q.); Center for Alzheimer Research and Treatment, Brigham and Women's Hospital (R.A., R.A.S.), Boston, MA; Banner Alzheimer's Institute (H.P., K.C., P.T., J.B.L., E.M.R.), Phoenix, AZ; Grupo de Neurociencias (D.C.A.-A., V.T., C.M., F.L., Y.T.Q.), Universidad de Antioquia; Instituto de Alta Tecnologia Medica (G.C.), Medellin, Colombia; and Athinoula A Martinos Center for Biomedical Imaging (Y.T.Q.), Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631170PMC
October 2017

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

JAMA 2016 Jul;316(1):40-50

Harvard University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://scholarworks.iupui.edu/bitstream/handle/1805/11938/F
Web Search
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2016.8655DOI Listing
July 2016

What are we willing to accept for preventing Alzheimer's disease? - Investigators' reply.

Lancet Neurol 2016 06 9;15(7):660-661. Epub 2016 May 9.

Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(16)30055-2DOI Listing
June 2016

Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation.

Neurology 2015 Jan 3;84(2):206-8. Epub 2014 Dec 3.

From the Neuroscience Research Institute (K.S.K., M.L.A.), University of California, Santa Barbara; Grupo de Neurociencias de Antioquia (C.M., L.L., G.G., L.M., S.M., S.R.R., H.L., M.G., F.L.), Universidad de Antioquia, Medellín, Colombia; Banner Alzheimer's Institute (J.B.L., P.N.T., E.M.R.), Phoenix, AZ; and Genentech (W.C., S.S., C.H.), South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336083PMC
January 2015

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.

Alzheimers Dement 2014 Nov 21;10(6):666-74. Epub 2014 Apr 21.

Banner Alzheimer's Institute, Phoenix, AZ, USA; Arizona Alzheimer's Consortium, Phoenix, AZ, USA; Department of Psychiatry, University of Arizona, Tucson, AZ, USA; Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2014.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201904PMC
November 2014

When should neuroprotective drugs move from mice to men?

Authors:
Pierre N Tariot

Lancet Neurol 2014 Jul 27;13(7):641-3. Epub 2014 May 27.

Banner Alzheimer's Institute, 901 E Willetta Street, Phoenix, AZ 85006, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(14)70112-7DOI Listing
July 2014

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Neurology 2014 Jul 13;83(3):253-60. Epub 2014 Jun 13.

From the Departments of Neurology (D.C.R., J.C.M., R.J.B.), Biostatistics (C.X.), and Psychiatry (A.G.), Washington University School of Medicine, St. Louis, MO; Neurologische Klinik Ludwig-Maximilians-Universität Munich and German Center for Neurodegenerative Diseases (A.D.), Munich, Germany; Department of Neurosciences (P.S.A.), University of California San Diego; Mental Health Research Institute (C.L.M.), University of Melbourne, Australia; Grupo de Neurociencias de Antioquia (N.A.-B., F.L., S.M.), Universidad de Antioquia, Medellín, Colombia; Department of Neurology (E.M.), University of Pittsburgh, PA; Department of Neurology (T.B.), University of Washington, Seattle; Banner Alzheimer's Institute (J.B.S.L., E.M.R., P.N.T.), Phoenix, AZ; Neuroscience Research Australia and University of New South Wales (P.R.S.), Sydney, Australia; Edith Cowan University (R.M.), Western Australia; Easton Center for Alzheimer's Disease Research at UCLA (J.M.R.), Los Angeles, CA; Department of Neurology (R.P.M.), Columbia University, New York, NY; Queen Square Institute of Neurology (N.C.F.), University College London; Department of Neurology (S.S.), Warren Alpert Medical School, Brown University, Providence, RI; and Center for Alzheimer Research and Treatment (R.S.), Brigham and Women's Hospital and Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117367PMC
July 2014

Endpoints in preclinical Alzheimer's disease trials.

J Clin Psychiatry 2014 Jun;75(6):661-2

Banner Alzheimer's Institute, 901 E Willetta St, Phoenix, AZ 85006

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.14com09235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459723PMC
June 2014

As time goes by.

Prim Care Companion CNS Disord 2013 25;15(2). Epub 2013 Apr 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.13alz01518DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733530PMC
August 2013

Ushering in the study and treatment of preclinical Alzheimer disease.

Nat Rev Neurol 2013 Jul 11;9(7):371-81. Epub 2013 Jun 11.

Banner Alzheimer's Institute, 901 East Willetta Street, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2013.107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084675PMC
July 2013

Updates to diagnostic guidelines for Alzheimer's disease.

Prim Care Companion CNS Disord 2011 ;13(5)

College of Medicine, University of Arizona, Tucson, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.11f01262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267500PMC
June 2013

Cessation of donepezil is associated with clinical decline in patients with moderate-to-severe Alzheimer's disease compared to continuation of donepezil or addition or substitution of memantine.

Authors:
Pierre N Tariot

Evid Based Med 2013 Apr 26;18(2):62-3. Epub 2012 Jun 26.

Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/eb-2012-100722DOI Listing
April 2013

The clinical problem of neuropsychiatric signs and symptoms in dementia.

Continuum (Minneap Minn) 2013 Apr;19(2 Dementia):382-96

Banner Alzheimer’s Institute 901 East Willetta St, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.CON.0000429177.14354.83DOI Listing
April 2013

Falling down.

Prim Care Companion CNS Disord 2012 26;14(2). Epub 2012 Apr 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.12alz01370DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425468PMC
October 2012

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.

BMC Res Notes 2012 Jun 8;5:283. Epub 2012 Jun 8.

Banner Alzheimer's Institute, 901 E. Willetta Street, Third Floor, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-0500-5-283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493328PMC
June 2012

Mild cognitive impairment: diagnosis and treatment dilemmas.

Prim Care Companion CNS Disord 2011 ;13(4)

Banner Alzheimer's Institute, 901 E. Willetta St, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/PCC.11alz01241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219518PMC
April 2012

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Authors:
Trygve E Bakken J Cooper Roddey Srdjan Djurovic Natacha Akshoomoff David G Amaral Cinnamon S Bloss B J Casey Linda Chang Thomas M Ernst Jeffrey R Gruen Terry L Jernigan Walter E Kaufmann Tal Kenet David N Kennedy Joshua M Kuperman Sarah S Murray Elizabeth R Sowell Lars M Rimol Morten Mattingsdal Ingrid Melle Ingrid Agartz Ole A Andreassen Nicholas J Schork Anders M Dale Michael Weiner Paul Aisen Ronald Petersen Clifford R Jack William Jagust John Q Trojanowki Arthur W Toga Laurel Beckett Robert C Green Andrew J Saykin John Morris Enchi Liu Tom Montine Anthony Gamst Ronald G Thomas Michael Donohue Sarah Walter Devon Gessert Tamie Sather Danielle Harvey John Kornak Anders Dale Matthew Bernstein Joel Felmlee Nick Fox Paul Thompson Norbert Schuff Gene Alexander Charles DeCarli Dan Bandy Robert A Koeppe Norm Foster Eric M Reiman Kewei Chen Chet Mathis Nigel J Cairns Lisa Taylor-Reinwald J Q Trojanowki Les Shaw Virginia M Y Lee Magdalena Korecka Karen Crawford Scott Neu Tatiana M Foroud Steven Potkin Li Shen Zaven Kachaturian Richard Frank Peter J Snyder Susan Molchan Jeffrey Kaye Joseph Quinn Betty Lind Sara Dolen Lon S Schneider Sonia Pawluczyk Bryan M Spann James Brewer Helen Vanderswag Judith L Heidebrink Joanne L Lord Kris Johnson Rachelle S Doody Javier Villanueva-Meyer Munir Chowdhury Yaakov Stern Lawrence S Honig Karen L Bell John C Morris Beau Ances Maria Carroll Sue Leon Mark A Mintun Stacy Schneider Daniel Marson Randall Griffith David Clark Hillel Grossman Effie Mitsis Aliza Romirowsky Leyla deToledo-Morrell Raj C Shah Ranjan Duara Daniel Varon Peggy Roberts Marilyn Albert Chiadi Onyike Stephanie Kielb Henry Rusinek Mony J de Leon Lidia Glodzik Susan De Santi P Murali Doraiswamy Jeffrey R Petrella R Edward Coleman Steven E Arnold Jason H Karlawish David Wolk Charles D Smith Greg Jicha Peter Hardy Oscar L Lopez MaryAnn Oakley Donna M Simpson Anton P Porsteinsson Bonnie S Goldstein Kim Martin Kelly M Makino M Saleem Ismail Connie Brand Ruth A Mulnard Gaby Thai Catherine Mc-Adams-Ortiz Kyle Womack Dana Mathews Mary Quiceno Ramon Diaz-Arrastia Richard King Myron Weiner Kristen Martin-Cook Michael DeVous Allan I Levey James J Lah Janet S Cellar Jeffrey M Burns Heather S Anderson Russell H Swerdlow Liana Apostolova Po H Lu George Bartzokis Daniel H S Silverman Neill R Graff-Radford Francine Parfitt Heather Johnson Martin R Farlow Ann Marie Hake Brandy R Matthews Scott Herring Christopher H van Dyck Richard E Carson Martha G MacAvoy Howard Chertkow Howard Bergman Chris Hosein Sandra Black Bojana Stefanovic Curtis Caldwell Ging-Yuek Robin Hsiung Howard Feldman Benita Mudge Michele Assaly Andrew Kertesz John Rogers Dick Trost Charles Bernick Donna Munic Diana Kerwin Marek-Marsel Mesulam Kristina Lipowski Chuang-Kuo Wu Nancy Johnson Carl Sadowsky Walter Martinez Teresa Villena Raymond Scott Turner Kathleen Johnson Brigid Reynolds Reisa A Sperling Keith A Johnson Gad Marshall Meghan Frey Jerome Yesavage Joy L Taylor Barton Lane Allyson Rosen Jared Tinklenberg Marwan Sabbagh Christine Belden Sandra Jacobson Neil Kowall Ronald Killiany Andrew E Budson Alexander Norbash Patricia Lynn Johnson Thomas O Obisesan Saba Wolday Salome K Bwayo Alan Lerner Leon Hudson Paula Ogrocki Evan Fletcher Owen Carmichael John Olichney Smita Kittur Michael Borrie T-Y Lee Rob Bartha Sterling Johnson Sanjay Asthana Cynthia M Carlsson Steven G Potkin Adrian Preda Dana Nguyen Pierre Tariot Adam Fleisher Stephanie Reeder Vernice Bates Horacio Capote Michelle Rainka Douglas W Scharre Maria Kataki Earl A Zimmerman Dzintra Celmins Alice D Brown Godfrey D Pearlson Karen Blank Karen Anderson Robert B Santulli Eben S Schwartz Kaycee M Sink Jeff D Williamson Pradeep Garg Franklin Watkins Brian R Ott Henry Querfurth Geoffrey Tremont Stephen Salloway Paul Malloy Stephen Correia Howard J Rosen Bruce L Miller Jacobo Mintzer Crystal Flynn Longmire Kenneth Spicer Elizabether Finger Irina Rachinsky Dick Drost Terry Jernigan Connor McCabe Ellen Grant Thomas Ernst Josh Kuperman Yoon Chung Sarah Murray Cinnamon Bloss Burcu Darst Lexi Pritchett Ashley Saito David Amaral Mishaela DiNino Bella Eyngorina Elizabeth Sowell Suzanne Houston Lindsay Soderberg Walter Kaufmann Peter van Zijl Hilda Rizzo-Busack Mohsin Javid Natasha Mehta Erika Ruberry Alisa Powers Bruce Rosen Nitzah Gebhard Holly Manigan Jean Frazier David Kennedy Lauren Yakutis Michael Hill Jeffrey Gruen Joan Bosson-Heenan Heatherly Carlson

Proc Natl Acad Sci U S A 2012 Mar 16;109(10):3985-90. Epub 2012 Feb 16.

Medical Scientist Training Program, University of California at San Diego, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1105829109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309762PMC
March 2012

Atypical antipsychotics in the elderly: a review of therapeutic trends and clinical outcomes.

Expert Opin Pharmacother 2009 Oct;10(15):2407-14

Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656560903200659DOI Listing
October 2009

Can lithium or valproate untie tangles in Alzheimer's disease?

J Clin Psychiatry 2009 Jun;70(6):919-21

Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.09com05331DOI Listing
June 2009

Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study.

Am J Psychiatry 2009 May 15;166(5):583-90. Epub 2009 Apr 15.

Department of Psychiatry and Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2008.08081218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891018PMC
May 2009

Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium.

Neurobiol Aging 2008 Nov 22;29(11):1631-43. Epub 2007 May 22.

Center for Aging and Developmental Biology, Aab Institute for Biomedical Research, University of Rochester School of Medicine and Dentistry, Box 645, 601 Elmwood Avenue, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2007.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621111PMC
November 2008

Non-cholinergic drug development for Alzheimer's disease.

Expert Opin Drug Discov 2008 Jul;3(7):745-60

Banner Alzheimer's Institute, 901 East Willetta St., Phoenix, Arizona, AZ 85006, USA +1 602 239 6967 ; +1 602 239 6914 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17460441.3.7.745DOI Listing
July 2008

ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.

Neuropsychopharmacology 2008 Apr 18;33(5):957-70. Epub 2007 Jul 18.

Department of Psychiatry and Neurosciences, University of California, San Diego, CA 92161, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.npp.1301492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2553721PMC
April 2008

Psychosis and agitation in dementia: should general psychiatrists care?

Authors:
Pierre N Tariot

J Clin Psychiatry 2008 Mar;69(3):339-40

Memory Disorders Center, Banner Alzheimer's Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v69n0301DOI Listing
March 2008

A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.

Alzheimer Dis Assoc Disord 2007 Apr-Jun;21(2):136-43

Yale University School of Medicine, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0b013e318065c495DOI Listing
September 2007

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics.

Curr Alzheimer Res 2007 Jul;4(3):325-35

University of Rochester Medical Center, Program in Neurobehavioral Therapeutics, Monroe Community Hospital, 435 East Henrietta Road, Rochester, NY 14620, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720507781077214DOI Listing
July 2007

Meta-analysis of six-month memantine trials in Alzheimer's disease.

Alzheimers Dement 2007 Jan;3(1):7-17

Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2006.10.004DOI Listing
January 2007

Clinical trials of amyloid-based therapies for Alzheimer's disease.

Authors:
Pierre N Tariot

CNS Spectr 2007 Jan;12(1 Suppl 1):7-10

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s1092852900025888DOI Listing
January 2007

Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

Am J Geriatr Psychiatry 2006 Sep 11;14(9):767-76. Epub 2006 Aug 11.

Memory Disorders Center, Banner Alzheimer's Disease Institute, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JGP.0000196628.12010.35DOI Listing
September 2006

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment.

Neurology 2006 Jul;67(1):57-63

Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1769, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000223333.42368.f1DOI Listing
July 2006

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Authors:
Pierre N Tariot

J Clin Psychiatry 2006 ;67 Suppl 3:15-22; quiz 23

Memory Disorders Center, Banner Alzheimer's Disease Institute, Phoenix, AZ 85006, USA.

View Article

Download full-text PDF

Source
May 2006

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

Curr Alzheimer Res 2005 Dec;2(5):541-51

Department of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, 90033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720505774932287DOI Listing
December 2005

What do people at risk for Alzheimer disease think about surrogate consent for research?

Neurology 2005 Nov;65(9):1395-401

Department of Psychiatry, Center for Behavioral and Decision Sciences in Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000183144.61428.73DOI Listing
November 2005

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Am J Geriatr Psychiatry 2005 Nov;13(11):942-9

Department of Psychiatry, The Center for Aging and Developmental Biology, Univ. of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://ajgponline.org/cgi/doi/10.1176/appi.ajgp.13.11.942
Publisher Site
http://dx.doi.org/10.1176/appi.ajgp.13.11.942DOI Listing
November 2005

Pharmacological treatment of neuropsychiatric symptoms of dementia.

Authors:
Pierre N Tariot

JAMA 2005 May;293(18):2212; author reply 2212

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.293.18.2212-aDOI Listing
May 2005